Zentalis Pharmaceuticals, Inc. (ZNTL) Current Reports & Earnings Releases
Upcoming
- 2026-11-09 Earnings Release Estimated
| Filed | Form | Items | Filing |
|---|---|---|---|
| 2026-08-14 | 8-K | Other Events, Financial Statements & Exhibits | SEC |
| 2026-08-06 | 8-K | Results of Operations, Reg FD Disclosure | SEC |
| 2026-06-18 | 8-K | Shareholder Vote Results | SEC |
| 2026-05-27 | 8-K | Officer / Director Changes | SEC |
| 2026-05-21 | 8-K | Reg FD Disclosure, Other Events | SEC |
| 2026-05-12 | 8-K | Results of Operations, Reg FD Disclosure | SEC |
| 2026-05-05 | 8-K | Reg FD Disclosure, Other Events | SEC |
| 2026-04-17 | 8-K | Reg FD Disclosure | SEC |
| 2026-04-09 | 8-K | Reg FD Disclosure, Other Events | SEC |
| 2026-03-26 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2026-01-09 | 8-K | Reg FD Disclosure, Other Events | SEC |
| 2025-12-15 | 8-K | Officer / Director Changes, Other Events | SEC |
| 2025-11-10 | 8-K | Results of Operations, Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2025-08-26 | 8-K | Officer / Director Changes, Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2025-08-06 | 8-K | Results of Operations, Reg FD Disclosure | SEC |
| 2025-06-18 | 8-K | Shareholder Vote Results | SEC |
| 2025-06-02 | 8-K | Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2025-05-20 | 8-K | Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2025-05-14 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2025-04-28 | 8-K | Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2025-03-26 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2025-03-17 | 8-K | Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2025-01-29 | 8-K | Reg FD Disclosure, Other Events, Financial Statements & Exhibits | SEC |
| 2025-01-28 | 8-K | Item 2.05, Reg FD Disclosure, Other Events, Financial Statements & Exhibits | SEC |
| 2024-11-13 | 8-K | Officer / Director Changes, Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2024-09-16 | 8-K | Reg FD Disclosure, Other Events, Financial Statements & Exhibits | SEC |
| 2024-08-09 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2024-06-21 | 8-K | Shareholder Vote Results | SEC |
| 2024-06-03 | 8-K | Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2024-05-29 | 8-K | Officer / Director Changes | SEC |
| 2024-05-07 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2024-04-11 | 8-K | Officer / Director Changes | SEC |
| 2024-04-09 | 8-K | Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2024-02-27 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2024-02-15 | 8-K | Charter Amendments, Financial Statements & Exhibits | SEC |
| 2024-01-25 | 8-K | Listing Notice, Officer / Director Changes, Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2024-01-08 | 8-K | Reg FD Disclosure, Other Events, Financial Statements & Exhibits | SEC |
Sourced from SEC EDGAR 8-K/6-K filings. 8-K is the current-report form for US domestic issuers (Item 2.02 = earnings release); 6-K is the equivalent for foreign private issuers, including ADRs. Originals live on sec.gov.